Genomics and gene editing is a sector that is truly in its infancy, but as we have seen this past week, that’s not stopping investors from buying up companies in the sector at high valuations.

We all know about the red-hot sectors like electric vehicles, SPAC IPOs, and cloud based software, but the real investors know that the next industry to truly take off is in biotech, specifically in genomics.